Grants & Projects per year
Personal profile
Research interests
My research integrates developmental psychopathology with neuroscience to identify novel strategies for prevention and treatment of psychiatric disorders. This integrative approach has led me utilize diverse methods in my research to test research hypotheses, including structural and functional magnetic resonance imaging (MRI), neuromelanin-sensitive MRI, event-related potentials, multi-dimensional behavioral phenotypes, and longitudinal and genetically informed study designs.
Fingerprint
- 6 Similar Profiles
Collaborations and top research areas from the last five years
-
Metacognition Circuit Impairments Predicting Drug Use and Quality-of-Life in Human Opioid Addiction
Moeller, S. J. (PI), Lejuez, C. (CoPI), Perlman, G. (CoPI) & Gil, R. (CoI)
National Institute on Drug Abuse
06/1/26 → 02/28/27
Project: Research
-
Elucidating Cholinergic Relationships with Psychosis And Cognitive Deficits in Schizophrenia
Weinstein, J. (PI), Abi-Dargham, A. (CoPI), Gil, R. (CoPI), Moeller, S. J. (CoPI), Perlman, G. (CoPI), Slifstein, M. (CoPI) & Van Snellenberg, J. (CoPI)
National Institute of Mental Health
07/1/24 → 02/28/27
Project: Research
-
Developmental Pathways Model of Depression Heterogeneity
Kotov, R. (PI), Abi-Dargham, A. (CoPI), Klein, D. N. (CoPI), Kuan, P. F. (CoPI), Nelson, B. D. (CoPI) & Perlman, G. (CoPI)
National Institute of Mental Health
05/22/24 → 02/28/27
Project: Research
-
Neuromelanin MRI: A Tool for Non-Invasive Investigation of Dopaminergic Abnormalities in Adolescent Substance Use
Perlman, G. (PI), Abi-Dargham, A. (CoPI), Kotov, R. (CoPI), Moeller, S. J. (CoPI) & Van Snellenberg, J. (CoPI)
National Institute on Drug Abuse
09/15/23 → 06/30/27
Project: Research
-
A Randomized Double-Blind Placebo-Controlled Parallel-Group Study to Evaluate the Efficacy Safety and Tolerability of Luvadaxistat in Subjects With Cognitive Impairment Associated With Schizophrenia
Gil, R. (PI) & Perlman, G. (CoPI)
Neurocrine Biosciences Incorporated
08/17/24 → 08/16/26
Project: Research
-
A translational neuroscience & computational evaluation of a D1R partial agonist for schizophrenia (TRANSCENDS): Rationale and study design of a brain-based clinical trial
Fonteneau, C., Tamayo, Z., Price, A., Pan, L., Afriyie-Agyemang, Y., Agrawal, S., Butler, A., Cail, C., Calkins, M., Chakilam, A. R., Forselius-Bielen, K., Fram, G., Frazier, A., Gil, R., Govil, P., Gray, D. L., Grinband, J., Gur, R. C., Haubold, N. K. & Heffernan, Z. & 24 others, , Mar 2026, In: Journal of Psychiatric Research. 194, p. 196-210 15 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Auditory event-related potentials and psychosis dimensions
Trayvick, J., Perlman, G., Jonas, K. G., Donaldson, K. R., Foti, D., Bromet, E. J., Kotov, R. & Nelson, B. D., 2026, (Accepted/In press) In: Neuropsychopharmacology.Research output: Contribution to journal › Article › peer-review
-
Do Predictors of First-Onset Depression Differ Between Youth with and without Anxiety Disorders?
Grieshaber, A., Perlman, G., Kotov, R. & Klein, D. N., 2026, In: Journal of Clinical Child and Adolescent Psychology. 55, 4, p. 609-623 15 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Electrophysiological reactivity to emotional images and targets predicts the development of substance use disorders in adolescent girls
Trayvick, J., Perlman, G., Klein, D. N., Kotov, R. & Nelson, B. D., Oct 2026, In: Journal of Psychiatric Research. 201, p. 621-628 8 p.Research output: Contribution to journal › Article › peer-review
-
Prospective prediction of first-onset generalized and social anxiety disorders in adolescent girls
Liu, J., Yao, N., Perlman, G., Klein, D. N., Kotov, R. & Mu, W., Jun 2026, In: Journal of Anxiety Disorders. 120, 103153.Research output: Contribution to journal › Article › peer-review